Deep search
All
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Search
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Novo Nordisk’s Ozempic Gets FDA Approval
FDA approves Novo Nordisk's Ozempic to treat chronic kidney disease in those with diabetes, expanding its use
Expanded Ozempic approval in the U.S. could transform how doctors treat patients with chronic kidney disease, which involves a gradual loss of kidney function.
Novo Nordisk’s Ozempic Gets FDA Approval as Kidney-Disease Treatment
Ozempic, or semaglutide, can now be used to reduce the risk of worsening kidney disease or kidney failure in adults with type 2 diabetes and chronic kidney disease, Novo Nordisk said.
Ozempic Approved By FDA For Kidney Disease—In Ultra-Popular Drug’s Latest Approval
Regulators have approved the drug as a treatment for weight loss, Type 2 diabetes and lowering the risk of heart attacks and strokes.
10d
on MSN
Will Medicare End Ozempic Maker Novo Nordisk's Obesity Drug Boom?
Just how much Medicare price negotiations will negatively impact Novo Nordisk, though, depends on what the final negotiated ...
3h
Novo Nordisk shares have a long road back from 40% slump
Novo Nordisk A/S investors got a much-needed boost from last week’s trial results for an experimental weight-loss shot. But ...
17h
on MSN
Novo Nordisk A/S (NVO): A Bull Case Theory
We came across a bullish thesis on Novo Nordisk A/S (NVO) on Long-Term Pick’s Substack by Dan. In this article, we will ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
Black boxes recovered
Los Angeles wildfire updates
Cause of death revealed
Asteroid may hit Earth
Hamas confirms death
Blames DEI for crash
FDA approves painkiller
2 more victims in indictment
Signs education orders
Apologizes for old tweets
Searching for joyriders
Michigan priest loses license
Sexual misconduct accusation
To raise hourly pay
Recuses self from Act 10 suit
'As Tears Go By' singer dies
Shiffrin finishes 10th
Deputy shooting sentence
Ex-worker admits to theft
Olympic gold medalist dies
Confirmed interior secretary
Ebola outbreak in Uganda
Wildfire erupts in NC
Weekly jobless claims fall
Ground stop amid IT outage
Nashville bids for franchise
S3 release date revealed
US economy grew 2.3%
DOJ sues to block deal
Partners w/ US national labs
Feedback